[{"x_label":"Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 613)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":613,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Lymphoblastic Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000220","MONDO":"MONDO_0004967","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.96,"TPM_sd":4.13,"TPM_min":0,"TPM_25th_percentile":1.36,"TPM_median":2.69,"TPM_75th_percentile":4.87,"TPM_max":33.49},{"x_label":"Acute Myeloid Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 210)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":210,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Myeloid Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000222","MONDO":"MONDO_0018874","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.73,"TPM_sd":5.43,"TPM_min":0,"TPM_25th_percentile":1.06,"TPM_median":3.12,"TPM_75th_percentile":6.32,"TPM_max":36.98},{"x_label":"Adamantinomatous Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 58)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":58,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Adamantinomatous Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000069","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.15,"TPM_sd":2.14,"TPM_min":0.08,"TPM_25th_percentile":0.37,"TPM_median":0.56,"TPM_75th_percentile":1.21,"TPM_max":14.83},{"x_label":"Atypical choroid plexus papilloma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Atypical choroid plexus papilloma","GTEx_tissue_subgroup":"","EFO":"EFO_1000177","MONDO":"MONDO_0002684","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.52,"TPM_sd":1.25,"TPM_min":0.25,"TPM_25th_percentile":0.91,"TPM_median":1.57,"TPM_75th_percentile":2.16,"TPM_max":2.74},{"x_label":"Atypical Teratoid Rhabdoid Tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 59)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":59,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Atypical Teratoid Rhabdoid Tumor","GTEx_tissue_subgroup":"","EFO":"EFO_1002008","MONDO":"MONDO_0020560","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.46,"TPM_sd":5.38,"TPM_min":0,"TPM_25th_percentile":1.34,"TPM_median":2.14,"TPM_75th_percentile":2.88,"TPM_max":35.71},{"x_label":"Central neurocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Central neurocytoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000856","MONDO":"MONDO_0019134","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.2,"TPM_sd":1.81,"TPM_min":0.09,"TPM_25th_percentile":0.15,"TPM_median":0.21,"TPM_75th_percentile":1.75,"TPM_max":3.29},{"x_label":"Chordoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 8)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":8,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Chordoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0008978","MONDO":"MONDO_0008978","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.91,"TPM_sd":0.74,"TPM_min":0,"TPM_25th_percentile":0.41,"TPM_median":0.74,"TPM_75th_percentile":1.44,"TPM_max":1.98},{"x_label":"Choroid plexus carcinoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 15)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":15,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Choroid plexus carcinoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016718","MONDO":"MONDO_0016718","GTEx_tissue_subgroup_UBERON":"","TPM_mean":11.14,"TPM_sd":24.05,"TPM_min":0.14,"TPM_25th_percentile":0.56,"TPM_median":0.99,"TPM_75th_percentile":7.91,"TPM_max":90.3},{"x_label":"CNS Embryonal tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 20)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":20,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"CNS Embryonal tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005784","MONDO":"MONDO_0018843","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.8,"TPM_sd":16.47,"TPM_min":0.13,"TPM_25th_percentile":0.68,"TPM_median":1.66,"TPM_75th_percentile":7.87,"TPM_max":64.08},{"x_label":"CNS neuroblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"CNS neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0006130","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.48,"TPM_sd":10.55,"TPM_min":1.52,"TPM_25th_percentile":2.42,"TPM_median":3.31,"TPM_75th_percentile":11.96,"TPM_max":20.62},{"x_label":"Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 16)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":16,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000209","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.38,"TPM_sd":0.34,"TPM_min":0.06,"TPM_25th_percentile":0.16,"TPM_median":0.26,"TPM_75th_percentile":0.48,"TPM_max":1.39},{"x_label":"Desmoplastic infantile astrocytoma and ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Desmoplastic infantile astrocytoma and ganglioglioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0022963","MONDO":"MONDO_0016731","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.4,"TPM_sd":0.5,"TPM_min":0.08,"TPM_25th_percentile":0.11,"TPM_median":0.14,"TPM_75th_percentile":0.55,"TPM_max":0.97},{"x_label":"Diffuse hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 28)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":28,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse hemispheric glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016680","MONDO":"MONDO_0016680","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.12,"TPM_sd":7.05,"TPM_min":0.15,"TPM_25th_percentile":1,"TPM_median":2.67,"TPM_75th_percentile":4.21,"TPM_max":38.48},{"x_label":"Diffuse intrinsic pontine glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse intrinsic pontine glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.16,"TPM_sd":0.98,"TPM_min":0.1,"TPM_25th_percentile":0.35,"TPM_median":1.03,"TPM_75th_percentile":1.66,"TPM_max":2.74},{"x_label":"Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 164)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":164,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse midline glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.48,"TPM_sd":6.11,"TPM_min":0,"TPM_25th_percentile":0.52,"TPM_median":1.24,"TPM_75th_percentile":2.98,"TPM_max":35.27},{"x_label":"Dysembryoplastic neuroepithelial tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 39)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":39,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Dysembryoplastic neuroepithelial tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005551","MONDO":"MONDO_0005505","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.45,"TPM_sd":1.06,"TPM_min":0.01,"TPM_25th_percentile":0.11,"TPM_median":0.16,"TPM_75th_percentile":0.34,"TPM_max":6.46},{"x_label":"Embryonal tumor with multilayer rosettes  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 5)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Embryonal tumor with multilayer rosettes","GTEx_tissue_subgroup":"","EFO":"MONDO_0016715","MONDO":"MONDO_0016715","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.52,"TPM_sd":4.4,"TPM_min":1.19,"TPM_25th_percentile":3.83,"TPM_median":4.34,"TPM_75th_percentile":5.32,"TPM_max":12.9},{"x_label":"Ependymoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 163)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":163,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ependymoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000028","MONDO":"MONDO_0016698","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.83,"TPM_sd":1.23,"TPM_min":0.01,"TPM_25th_percentile":0.16,"TPM_median":0.43,"TPM_75th_percentile":0.97,"TPM_max":8.92},{"x_label":"Ewing sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ewing sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000174","MONDO":"MONDO_0012817","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.5,"TPM_sd":0.91,"TPM_min":0.25,"TPM_25th_percentile":0.84,"TPM_median":1.2,"TPM_75th_percentile":2.08,"TPM_max":3.53},{"x_label":"Ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 80)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":80,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ganglioglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0003094","MONDO":"MONDO_0016733","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.43,"TPM_sd":0.94,"TPM_min":0.02,"TPM_25th_percentile":0.14,"TPM_median":0.26,"TPM_75th_percentile":0.39,"TPM_max":7.95},{"x_label":"Ganglioneuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 45)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":45,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"All Cohorts","Disease":"Ganglioneuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000502","MONDO":"MONDO_0005035","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.53,"TPM_sd":2.72,"TPM_min":0.08,"TPM_25th_percentile":0.64,"TPM_median":1.23,"TPM_75th_percentile":3.55,"TPM_max":11.91},{"x_label":"Ganglioneuroma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 4)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"All Cohorts","Disease":"Ganglioneuroma","GTEx_tissue_subgroup":"","EFO":"EFO_0000500","MONDO":"MONDO_0005033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.26,"TPM_sd":0.23,"TPM_min":0.09,"TPM_25th_percentile":0.1,"TPM_median":0.2,"TPM_75th_percentile":0.36,"TPM_max":0.58},{"x_label":"Ganglioneuroma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ganglioneuroma","GTEx_tissue_subgroup":"","EFO":"EFO_0000500","MONDO":"MONDO_0005033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.16,"TPM_sd":0.11,"TPM_min":0.09,"TPM_25th_percentile":0.1,"TPM_median":0.1,"TPM_75th_percentile":0.2,"TPM_max":0.29},{"x_label":"Germinoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Germinoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0020580","MONDO":"MONDO_0020580","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.54,"TPM_sd":6.06,"TPM_min":0.55,"TPM_25th_percentile":1.21,"TPM_median":2.9,"TPM_75th_percentile":4.01,"TPM_max":20.79},{"x_label":"Glial-neuronal tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 24)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":24,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Glial-neuronal tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0016729","MONDO":"MONDO_0016729","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.13,"TPM_sd":2.04,"TPM_min":0.02,"TPM_25th_percentile":0.13,"TPM_median":0.32,"TPM_75th_percentile":0.84,"TPM_max":8.16},{"x_label":"Glioblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 5)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Glioblastoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0018177","MONDO":"MONDO_0018177","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.99,"TPM_sd":2.29,"TPM_min":0.06,"TPM_25th_percentile":0.38,"TPM_median":1.27,"TPM_75th_percentile":2.54,"TPM_max":5.72},{"x_label":"Hemangioblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 5)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Hemangioblastoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016748","MONDO":"MONDO_0016748","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.3,"TPM_sd":0.24,"TPM_min":0.04,"TPM_25th_percentile":0.16,"TPM_median":0.29,"TPM_75th_percentile":0.33,"TPM_max":0.68},{"x_label":"High-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 175)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":175,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"High-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0100342","MONDO":"MONDO_0100342","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.95,"TPM_sd":7.66,"TPM_min":0.01,"TPM_25th_percentile":0.52,"TPM_median":1.52,"TPM_75th_percentile":3.73,"TPM_max":57.89},{"x_label":"Infant-type hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Infant-type hemispheric glioma","GTEx_tissue_subgroup":"","EFO":"EFO_0005543","MONDO":"MONDO_0014695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.61,"TPM_sd":0.47,"TPM_min":0.15,"TPM_25th_percentile":0.27,"TPM_median":0.33,"TPM_75th_percentile":1.08,"TPM_max":1.28},{"x_label":"Low-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 412)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":412,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Low-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0021637","MONDO":"MONDO_0021637","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.47,"TPM_sd":0.85,"TPM_min":0,"TPM_25th_percentile":0.14,"TPM_median":0.24,"TPM_75th_percentile":0.45,"TPM_max":7.69},{"x_label":"Malignant peripheral nerve sheath tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 6)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Malignant peripheral nerve sheath tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0000760","MONDO":"MONDO_0017827","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.45,"TPM_sd":1.12,"TPM_min":0.33,"TPM_25th_percentile":0.61,"TPM_median":1.36,"TPM_75th_percentile":1.74,"TPM_max":3.39},{"x_label":"Medulloblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 237)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":237,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Medulloblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0002939","MONDO":"MONDO_0007959","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.44,"TPM_sd":10.54,"TPM_min":0.07,"TPM_25th_percentile":1.19,"TPM_median":1.81,"TPM_75th_percentile":3.28,"TPM_max":115.46},{"x_label":"Meningioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 42)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":42,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Meningioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016642","MONDO":"MONDO_0016642","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.77,"TPM_sd":2.5,"TPM_min":0,"TPM_25th_percentile":0.21,"TPM_median":0.32,"TPM_75th_percentile":0.52,"TPM_max":16.37},{"x_label":"Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 318)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":318,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"All Cohorts","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.91,"TPM_sd":3.67,"TPM_min":0.06,"TPM_25th_percentile":1.85,"TPM_median":3.24,"TPM_75th_percentile":5.21,"TPM_max":47.65},{"x_label":"Neuroblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 7)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":7,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.61,"TPM_sd":1.36,"TPM_min":0.06,"TPM_25th_percentile":0.3,"TPM_median":2.23,"TPM_75th_percentile":2.48,"TPM_max":3.41},{"x_label":"Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 137)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":137,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.94,"TPM_sd":3.22,"TPM_min":0.1,"TPM_25th_percentile":1.54,"TPM_median":3.09,"TPM_75th_percentile":5.39,"TPM_max":21.06},{"x_label":"Neurofibroma/Plexiform  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 20)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":20,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Neurofibroma/Plexiform","GTEx_tissue_subgroup":"","EFO":"EFO_0000658","MONDO":"MONDO_0003304","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.34,"TPM_sd":0.41,"TPM_min":0.02,"TPM_25th_percentile":0.11,"TPM_median":0.2,"TPM_75th_percentile":0.36,"TPM_max":1.67},{"x_label":"Non-germinomatous germ cell tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 5)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Non-germinomatous germ cell tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0020580","MONDO":"MONDO_0020580","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.48,"TPM_sd":4.2,"TPM_min":0.13,"TPM_25th_percentile":0.24,"TPM_median":0.88,"TPM_75th_percentile":8.05,"TPM_max":8.09},{"x_label":"Oligodendroglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 62)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":62,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Oligodendroglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0000632","MONDO":"MONDO_0016695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.47,"TPM_sd":0.65,"TPM_min":0.01,"TPM_25th_percentile":0.16,"TPM_median":0.26,"TPM_75th_percentile":0.53,"TPM_max":4.19},{"x_label":"Pilocytic astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Pilocytic astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016691","MONDO":"MONDO_0016691","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.75,"TPM_sd":1.11,"TPM_min":0.06,"TPM_25th_percentile":0.09,"TPM_median":0.14,"TPM_75th_percentile":1.11,"TPM_max":3.53},{"x_label":"Pineoblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 14)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":14,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Pineoblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000475","MONDO":"MONDO_0016722","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.73,"TPM_sd":7.44,"TPM_min":0.03,"TPM_25th_percentile":0.89,"TPM_median":1.59,"TPM_75th_percentile":4.06,"TPM_max":25.01},{"x_label":"Sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 16)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":16,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000691","MONDO":"MONDO_0005089","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.17,"TPM_sd":1,"TPM_min":0.08,"TPM_25th_percentile":0.57,"TPM_median":0.96,"TPM_75th_percentile":1.58,"TPM_max":4.16},{"x_label":"Schwannoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 27)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":27,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Schwannoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000693","MONDO":"MONDO_0002546","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.48,"TPM_sd":0.36,"TPM_min":0.04,"TPM_25th_percentile":0.2,"TPM_median":0.46,"TPM_75th_percentile":0.6,"TPM_max":1.73},{"x_label":"Subependymal Giant Cell Astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 14)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":14,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Subependymal Giant Cell Astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016693","MONDO":"MONDO_0016693","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.51,"TPM_sd":0.31,"TPM_min":0.12,"TPM_25th_percentile":0.32,"TPM_median":0.45,"TPM_75th_percentile":0.69,"TPM_max":1.31},{"x_label":"Teratoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 9)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":9,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Teratoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0002601","MONDO":"MONDO_0002601","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.69,"TPM_sd":0.82,"TPM_min":0.01,"TPM_25th_percentile":0.16,"TPM_median":0.37,"TPM_75th_percentile":0.83,"TPM_max":2.29},{"x_label":"Wilms tumor  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 129)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":129,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Wilms tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0006058","MONDO":"MONDO_0006058","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.73,"TPM_sd":3.78,"TPM_min":0.36,"TPM_25th_percentile":2.6,"TPM_median":4.92,"TPM_75th_percentile":7.68,"TPM_max":20.45}]